LabCorp pursuing an $8B PPD buyout, tie up with Covance — report
Rumors of a potential buyout of PPD heated up to the boiling point over the weekend as Reuters reported that LabCorp has been in talks to acquire the CRO for more than $8 billion, including debt.
If successful, a deal would follow LabCorp’s 2015 acquisition of Covance. But it’s far from certain. The wire service reports that several firms have been interested in an auction for PPD, which has been at the center of buyout rumors for some time.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.